Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. 2011
  2. Published

    Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes

    Cangemi, C., Skov, V., Poulsen, M. K., Funder, J., Twal, W. O., Gall, M., Hjortdal, Vibeke Elisabeth, Jespersen, M. L., Kruse, T. A., Aagard, J., Parving, H., Knudsen, S., Høilund-Carlsen, P., Rossing, Peter, Henriksen, J. E., Argraves, W. S. & Rasmussen, L. M., Nov 2011, In: Clinical Chemistry. 57, 11, p. 1556-65 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Endothelial Progenitor Cells in Long-Standing Asymptomatic Type 1 Diabetic Patients with or without Diabetic Nephropathy

    Reinhard, H., Jacobsen, P. K., Lajer, M., Tarnow, L., Astrup, A. S., Kim, W. Y., Pedersen, N., Billestrup, Nils, Mandrup-Poulsen, Thomas, Parving, H. & Rossing, Peter, 2011, In: Nephron Clinical Practice. 118, 3, p. c309-c314 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria

    Reinhard, H., Nybo, M., Hansen, Peter Riis, Wiinberg, N., Kjær, Andreas, Petersen, C. L., Winther, Kaj, Parving, H., Rasmussen, L. M., Rossing, Peter & Jacobsen, P., 2011, In: Cardiovascular Diabetology. 10, p. 70

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 12937790